
Sign up to save your podcasts
Or


AT&T makes a $49 billion bid for DirecTV, while AstraZeneca turns down a $117 billion offer from Pfizer. Our analysts try to make sense of it all and offer up a couple of merger-related ideas of their own.
By The Motley Fool4.7
16041,604 ratings
AT&T makes a $49 billion bid for DirecTV, while AstraZeneca turns down a $117 billion offer from Pfizer. Our analysts try to make sense of it all and offer up a couple of merger-related ideas of their own.

3,221 Listeners

1,487 Listeners

808 Listeners

948 Listeners

520 Listeners

1,168 Listeners

2,184 Listeners

825 Listeners

1,423 Listeners

1,039 Listeners

9,717 Listeners

195 Listeners

826 Listeners

85 Listeners

585 Listeners

1,039 Listeners

54 Listeners